Clinical Trial Update: Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pembrolizumab in patients with early-stage extranodal NK/T-cell lymphoma, nasal type (nasal cavity or nasopharynx); results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis), NK/T-Cell Lymphoma of Nasopharynx (Diagnosis) | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-23